author-photo

Carlos Sattler

Merck & Co.

11

Papers

3099

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Examples of Novel Registered Prophylactic Vaccines, HPV, and JEV

2012
Show All
- Source
- Cite
- Save
Citations (1)
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.

2010 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (157)
Impact of a quadrivalent HPV6/11/16/18 vaccine in Mexican women: public health implications for the region.

2009 Archives of Medical Research
Show All
- Source
- Cite
- Save
Citations (12)
Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

2008 Vaccine
Show All
- Source
- Cite
- Save
Citations (70)
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

2007 The Lancet
Show All
- Source
- Cite
- Save
Citations (502)
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (1639)
Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines

2007 Clinical and Vaccine Immunology
Show All
- Source
- Cite
- Save
Citations (43)
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

2007 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (165)